Search results

87 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
New insights into side effects can help prostate cancer patients choose treatments
In the Journal of the American Medical Association, a study led by UNC Lineberger member Ronald C. Chen, MD, examines quality-of-life outcomes for modern treatment choices most patients will face, including active surveillance, radical prostatectomy, external beam radiation treatment, and brachytherapy.
Located in News
Located in Newsroom / UNC Lineberger in the News
Researchers awarded grant to study strategy to improve immunotherapy response
With a $1.74 million grant from the NIH, UNC Lineberger researchers led by H. Shelton Earp, MD, will study a potential new strategy for improving immunotherapy drug responses in patients with melanoma.
Located in News
Patients and their records agree on medical history for most maladies
A study led by UNC Lineberger researcher Ronald Chen, MD, found that a group of prostate cancer patients reliably reported their own medical histories when their responses were compared to their medical records.
Located in News
Located in Newsroom / UNC Lineberger in the News
Located in Newsroom / UNC Lineberger in the News
UNC Lineberger researchers speak at governor's mansion for launch of Metastatic Breast Cancer Awareness Month
N.C. Gov. Roy Cooper declared April as Metastatic Breast Cancer Awareness Month in North Carolina to bring attention to this second-leading cause of cancer death among women. UNC Lineberger researchers joined First Lady Kristin Cooper at the Executive Mansion on Monday at a luncheon hosted by the North Carolina Oncology Navigator Association.
Located in News
Broad support exists for larger warnings on cigarette packs
A study led by UNC Lineberger researcher Adam Goldstein, MD, MPH, and Sarah Kowitt, MPH, found broad support, even among smokers, for increasing the size of health warnings on cigarette packs.
Located in News
Located in Newsroom / UNC Lineberger in the News
'Good' bacteria is possible solution for unchecked inflammation in bowel diseases
In a study published in journal Nature Immunology, researchers led by UNC Lineberger member Jenny P.Y. Ting, PhD, described how inflammation can go unchecked in the absence of a certain inflammation inhibitor called NLRP12. In a harmful feedback loop, this inflammation can upset the balance of bacteria living in the gut. Beneficial bacteria may be the key to reversing inflammation in the absence of this key regulator.
Located in News